| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |